Akorn’s bankruptcy, recalls bring a drug to treat lead poisoning into shortage
27 Jul 2023
A drug used to treat lead poisoning is now in short supply after Akorn Pharmaceuticals filed for bankruptcy and many of its products were recalled this spring.
Dimercaprol is on the FDA’s drug shortages list, with no date for resolution listed.
It’s “very frustrating” not to have an essential antidote available, as another injectable product that can be used to treat lead poisoning is also not readily available, according to Erin Fox, an expert on drug shortages and an adjunct professor at the College of Pharmacy at the University of Utah.
Preview
Source: EndPoints
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
SIGN UP
LOG IN
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.